Pioglitazone Randomised Italian Study on Metabolic Syndrome (PRISMA): effect of pioglitazone with metformin on HDL-C levels in Type 2 diabetic patients (Q86430406)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 March 2013

Language	Label	Description	Also known as
English	Pioglitazone Randomised Italian Study on Metabolic Syndrome (PRISMA): effect of pioglitazone with metformin on HDL-C levels in Type 2 diabetic patients	scientific article published on 19 March 2013

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Pioglitazone Randomised Italian Study on Metabolic Syndrome (PRISMA): effect of pioglitazone with metformin on HDL-C levels in Type 2 diabetic patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

metabolic syndrome

1 reference

based on heuristic

inferred from title

0 references

Angelina Passaro

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

S Genovese

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

P Brunetti

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

D Cucinotta

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

PRISMA study group

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

C G Egan

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

B Chinea

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

F Bravi

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

C Di Pietro

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

19 March 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

606-616

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

https://scigraph.springernature.com/pub.10.3275/8895

0 references

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance and its treatment by thiazolidinediones

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone plus a sulphonylurea or metformin is associated with increased lipoprotein particle size in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone for diabetes prevention in impaired glucose tolerance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Approved IFCC reference method for the measurement of HbA1c in human blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apolipoprotein measurements: is more widespread use clinically indicated?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23511244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23511244%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q86430406&oldid=1933886301"